BIOATLA, INC. (BCAB) EBITDA
- 2026-06-30: Basis Reported; EBITDA $227.00K*; Operating income $227.00K; Depreciation and amortization $0.00*.
- 2026-03-31: Basis Reported; EBITDA -$9.19M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$9.24M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$13.73M*; Operating income -$13.79M; Depreciation and amortization $56.00K*.
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $227.00K* | $227.00K | $0.00* | (m) | (m) | (m) | -$419.00K* | (m) | $3.34M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$9.19M | (m) | (m) | (m) | (m) | (m) | -$5.27M | (m) | $4.58M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$9.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$13.73M* | -$13.79M | $56.00K* | (m) | (m) | (m) | -$9.88M* | (m) | $9.54M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$18.53M* | -$18.65M | $115.00K* | (m) | (m) | (m) | -$14.12M* | (m) | $13.68M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$17.43M | (m) | (m) | (m) | (m) | (m) | -$16.29M | (m) | $12.36M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$16.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$11.04M* | -$11.27M | $228.00K* | (m) | (m) | (m) | -$5.13M* | (m) | $16.39M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$21.74M* | -$21.97M | $229.00K* | (m) | (m) | (m) | -$19.19M* | (m) | $16.20M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$24.22M | (m) | (m) | (m) | (m) | (m) | -$30.83M | (m) | $18.85M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$28.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$34.75M* | -$35.02M | $270.00K* | (m) | (m) | (m) | -$27.34M* | (m) | $28.40M | (m) | (m) |
|---|
| 2023-06-30 | Reported | -$36.91M* | -$37.20M | $290.00K* | (m) | (m) | (m) | -$24.09M* | (m) | $30.96M | (m) | (m) |
|---|
| 2023-03-31 | Reported | -$28.64M | (m) | (m) | (m) | (m) | (m) | -$22.65M | (m) | $21.70M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$28.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$25.88M* | -$26.18M | $300.00K* | (m) | (m) | (m) | -$24.02M* | (m) | $19.84M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$28.77M* | -$29.05M | $288.00K* | (m) | (m) | (m) | -$16.92M* | (m) | $20.71M | (m) | (m) |
|---|
| 2022-03-31 | Reported | -$24.03M | (m) | (m) | (m) | (m) | (m) | -$25.14M | (m) | $16.92M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$23.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$23.32M* | -$23.70M | $380.00K* | (m) | (m) | (m) | -$12.73M* | (m) | $16.55M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$30.13M* | -$30.46M | $327.00K* | (m) | (m) | (m) | -$13.54M* | (m) | $14.85M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$18.49M | (m) | (m) | (m) | (m) | (m) | -$14.99M | (m) | $10.42M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$16.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$7.73M* | -$8.02M | $285.00K* | (m) | (m) | (m) | -$15.46M* | (m) | $4.86M | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$4.30M* | -$4.52M | $215.00K* | (m) | (m) | (m) | -$3.05M* | (m) | $2.92M | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$893,000.00 | (m) | (m) | (m) | (m) | (m) | -$3.81M | (m) | $1.66M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$58.93M | (m) | (m) | (m) | (m) | (m) | -$48.20M | (m) | $43.57M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$73.02M | (m) | (m) | (m) | (m) | (m) | -$71.94M | (m) | $63.09M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$128.47M | (m) | (m) | (m) | (m) | (m) | -$104.02M | (m) | $103.73M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$106.94M | (m) | (m) | (m) | (m) | (m) | -$90.42M | (m) | $79.35M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$95.11M | (m) | (m) | (m) | (m) | (m) | -$62.21M | (m) | $58.27M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$29.09M | (m) | (m) | (m) | (m) | (m) | -$36.33M | (m) | $19.93M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$27.41M | (m) | (m) | (m) | (m) | (m) | -$9.64M | (m) | $25.92M | (m) | (m) |
|---|